You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RXRX Sale Disclosure
Borgeson Blake · SEC Form 4 · Filed Aug 6, 2026
Sale
Calculated transaction value
$97.5K
Borgeson Blake Director
RXRX
Transaction date
Aug 4, 2026
Public filing date
Aug 6, 2026
Filing lag
Filed 2 days later
RXRX daily price context
Close on/before transaction
$3.31
Aug 4, 2026
First close after public filing
$3.22
Aug 7, 2026
30-day return after filing
+6.83%
Through Sep 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 30,000 shares @ $3.25
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001856094-26-000014
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$97.5K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Sale | Aug 4, 2026 | $97.5K |